119 related articles for article (PubMed ID: 6647799)
21. [Experimentally acquired resistance to tumor transplantation and the rejection of homologous skin transplantation in mice].
Enoki Y
Igaku To Seibutsugaku; 1967 Mar; 74(3):185-6. PubMed ID: 4861830
[No Abstract] [Full Text] [Related]
22. Acquired immunity to Ehrlich ascites tumor in mice after treatment with fresh or sonized tumor cells at various ages.
Yasuhira K
Acta Tuberc Jpn; 1966 Dec; 16(2):78-84. PubMed ID: 5984181
[No Abstract] [Full Text] [Related]
23. Induction of tolerance to immunogenic tumor antigens associated with lymphomagenesis in HOX11 transgenic mice.
Rosic-Kablar S; Chan K; Reis MD; Dubé ID; Hough MR
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13300-5. PubMed ID: 11069299
[TBL] [Abstract][Full Text] [Related]
24. Augmentation of in vivo antitumour activity of xenogeneic antiserum by autotransplanted normal spleen cells in mice.
Jakóbisiak M; Kańtoch M; Lasek W; Rozmysłowicz T; Obłakowski P; Dobaczewska H
Eur J Cancer (1965); 1981 Jan; 17(1):77-80. PubMed ID: 7262149
[No Abstract] [Full Text] [Related]
25. Action of theophylline on humoral and cellular immune response mechanisms.
Gillissen G
Allergol Immunopathol (Madr); 1981; Suppl 9():218-22. PubMed ID: 7349730
[No Abstract] [Full Text] [Related]
26. Serological studies of antigenic changes occurring in two lines of Ehrlich's ascites tumor after long periods of cultivation in vitro.
Monti-Bragadin C; Kieler J
Eur J Cancer (1965); 1968 Jul; 4(3):255-61. PubMed ID: 5760800
[No Abstract] [Full Text] [Related]
27. [Effect of the nucleic acids from the ascitic fluid of Ehrlich's tumor on its transplantability].
Belokhvostov AS; Grikurova NK
Vopr Onkol; 1981; 27(12):56-9. PubMed ID: 7324403
[TBL] [Abstract][Full Text] [Related]
28. Liberation of cell surface material by the insoluble trypsin derivative.
Kocemba-Sliwowska U; Kawiak J
Acta Biochim Pol; 1973; 20(2):113-8. PubMed ID: 4715517
[No Abstract] [Full Text] [Related]
29. [Influence of epsilon-aminocaproic acid on the growth of tumor cells in immunized mice].
Bonmassar E; Celi ML; Melan F; Testorelli C
Arch Ital Patol Clin Tumori; 1968; 11(1):187-94. PubMed ID: 5745501
[No Abstract] [Full Text] [Related]
30. Cross-presentation of antigens from apoptotic tumor cells by liver sinusoidal endothelial cells leads to tumor-specific CD8+ T cell tolerance.
Berg M; Wingender G; Djandji D; Hegenbarth S; Momburg F; Hämmerling G; Limmer A; Knolle P
Eur J Immunol; 2006 Nov; 36(11):2960-70. PubMed ID: 17039564
[TBL] [Abstract][Full Text] [Related]
31. [Changes in the immunobiologic properties of Ehrlich ascites carcinoma under the effect of suspension from normal rat tissues. II. Modification of the antigenic structure of the tumor demonstrated by the phenomenon of immunological increasing of growth].
Novikov DK
Tsitologiia; 1965; 7(3):423-7. PubMed ID: 5879871
[No Abstract] [Full Text] [Related]
32. Augmentation of antitumour activity of xenogeneic antiserum by normal xenogeneic spleen cells in mice.
Dobaczewska H; Lasek W; Marczak M; Obłakowski P; Jakóbisiak M
Folia Biol (Krakow); 1981; 29(1):77-81. PubMed ID: 7238955
[No Abstract] [Full Text] [Related]
33. [Gel filtration and immunoelectrophoresis of serum proteins in tumors and in tissue regressive processes].
Brucchieri A; Billitteri A
Sperimentale; 1969; 119(6):447-53. PubMed ID: 5406738
[No Abstract] [Full Text] [Related]
34. Dynamics of growth and regression of Ehrlich ascites carcinoma transplanted intraperitoneally in rats.
Janik P; Dabrowski M; Dux K
Arch Immunol Ther Exp (Warsz); 1966; 14(6):717-23. PubMed ID: 5957993
[No Abstract] [Full Text] [Related]
35. [Studies on the transfer of resistance to tumor growth in tumor-bearing animals].
Obayashi T
Kumamoto Igakkai Zasshi; 1966 Jan; 40(1):49-64. PubMed ID: 5953549
[No Abstract] [Full Text] [Related]
36. Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunity.
Kennedy RC; Shearer MH; Lowe DB; Jumper CA; Chiriva-Internati M; Bright RK
Cancer Immunol Immunother; 2004 Nov; 53(11):987-94. PubMed ID: 15156293
[TBL] [Abstract][Full Text] [Related]
37. [Immunoglobulins from a tumor-bearing body as possible regulators of the growth rate of relapses and metastases of Ehrlich carcinoma].
Donenko FV; Moroz LV
Biull Eksp Biol Med; 1995 Jan; 119(1):62-4. PubMed ID: 7718807
[No Abstract] [Full Text] [Related]
38. [Establishment of immunity against transplantation tumor by administration of gelatin and its derivatives in mice].
Enoki Y
Igaku To Seibutsugaku; 1971 Feb; 82(2):81-3. PubMed ID: 5165290
[No Abstract] [Full Text] [Related]
39. Augmented immunogenicity of tumor cell homogenates produced by infection with influenza virus.
Boone CW
Natl Cancer Inst Monogr; 1972 Dec; 35():301-7. PubMed ID: 4349150
[No Abstract] [Full Text] [Related]
40. [The role of serum humoral factors in metastasis and recurrence of Ehrlich carcinoma in mice].
Donenko FV; Sitdikova SM; Moroz LV
Biull Eksp Biol Med; 1997 Oct; 124(10):443-5. PubMed ID: 9410180
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
